Chapel Hill, NC, United States of America

Robert Tarran

This inventor holds 5 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: The University of North Carolina at Chapel Hill, Spryx Biosciences, Inc., Spyryx Biosciences, Inc.. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Tarran. Retrieved from https://idiyas.com/inventor/robert-tarran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 20.0

 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Tarran

Introduction

Robert Tarran is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomedical research, particularly in the development of peptide inhibitors that target calcium and sodium channels. With a total of 5 patents to his name, Tarran's work has the potential to impact various medical treatments.

Latest Patents

One of Tarran's latest patents is focused on peptide inhibitors of calcium channels. This invention relates to fragments of the SPLUNC1 protein that bind to calcium channels, inhibiting calcium influx into airway smooth muscle and other cells. The invention also includes methods for regulating calcium influx and treating or preventing disorders that are responsive to modulating calcium influx through these channels. Another significant patent involves peptide inhibitors of sodium channels. This invention highlights the ability of specialized non-naturally occurring peptides to bind to sodium channels, inhibiting their activation. It further discusses methods for regulating sodium absorption and fluid volume, as well as treating disorders that respond to modulating sodium absorption through these specialized peptides.

Career Highlights

Throughout his career, Robert Tarran has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Spyryx Biosciences, Inc. His research has been instrumental in advancing our understanding of ion channel modulation and its implications for various health conditions.

Collaborations

Tarran has collaborated with notable colleagues, including Monroe Jack Stutts and Scott Donaldson. These partnerships have contributed to the innovative research and development of his patented technologies.

Conclusion

Robert Tarran's contributions to the field of biomedical research through his innovative patents demonstrate his commitment to advancing medical science. His work in developing peptide inhibitors has the potential to lead to new treatments for disorders related to calcium and sodium channel modulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…